Notification, Precertification, and Appeals for Medications and Imaging Studies D-320.992
Our AMA will seek to have all notifications, precertifications and appeals for medications and imaging studies allowed equally by phone, e-mail, fax or letter.
Policy Timeline
Res. 132, A-07 Reaffirmed: CMS Rep. 01, A-17